Denifanstat Achieved All Endpoints in the Treatment of Moderate to Severe Acne in Phase 3 Clinical Trial in Acne in China: A Presentation at the 2025 Fall Clinical Dermatology Conference
October 24, 2025 07:00 ET Â | Source: Sagimet Biosciences Inc. Denifanstat met…
Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer
Media Release COPENHAGEN, Denmark; October 18, 2025 Updated data from the Phase…
Grand Cinemaz Expands Footprint with the Launch of its 2 Multiplexes in a Single Day – Ghaziabad & Saharanpur – A Vision to Redefine Cinema Across India
GHAZIABAD, India and SAHARANPUR, India, Oct. 10, 2025 /PRNewswire/ -- Grand Cinemaz, one of…
Mactores Signs Strategic AWS Partnership to Accelerate Enterprise GenAI Adoption by 80%
Mactores has partnered with AWS through a Strategic Collaboration Agreement and achieved…
Poppulo Becomes First Employee Comms and Digital Signage Company to Achieve Benchmark ISO Certification for Responsible AI
DENVER and CORK, Ireland, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Poppulo, a…
Kia America Posts Best Quarter and Highest YeartoDate Sales in Company History
Record third quarter pushes Kia’s total year-to-date sales up 9 percent over…
C4 Therapeutics Presents Cemsidomide Phase 1 Multiple Myeloma Data Supporting Potential Best-in-Class Profile at the International Myeloma Society Annual Meeting
September 20, 2025 11:00 ET Â | Source: C4 Therapeutics, Inc. Cemsidomide in…
Woxsen University Secures Top 5 Position in India in QS Business Masters Rankings 2025-26
HYDERABAD, India, Sept. 20, 2025 /PRNewswire/ --Â Woxsen University has achieved a significant…
Novo Nordisks oral semaglutide 25 mg (Wegovy in a pill*) delivered 16.6% weight loss in people with obesity in a newly published study
Oral semaglutide 25 mg (the once-daily pill formulation of Wegovy®) achieved significant…
New names set high standards for safety: Togg and firefly shake up the EV market
LEUVEN, BELGIUM – The chances are you won’t have heard of it…